alexa Overview of Xerodermatic Pigmentsum Mutations, Prognosis, and Treatment | Abstract
ISSN: 2169-0111

Advancements in Genetic Engineering
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication Open Access


Xeroderma Pigmentosum (XP) is a rare disorder, first described by Hebra and Kaposi. Cleaver provided a clear understanding of XP as it played a central role in DNA mutation in cancer [2]. This rare disorder is an autosomal recessive skin disorder where cells are unable to repair the damage caused by UV radiation. This leads to early skin changes, sunburns, dry skin and increased development of skin tumors and damage to the eyes brought on by UV light. Although rare, XP is present throughout the world in majority of ethnicities. Current statistics indicate that there are approximately 100 diagnosed cases in the UK. Furthermore, 1 in 1 million incidences are reported in the US. In addition, high rates have been reported in certain areas such as Japan and the Middle East.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Satyajit Patra


Xeroderma, Damage, sensitivity, Trans-Genesis,Insulin genetics

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version